» Articles » PMID: 37105017

Use of Risk-based Cervical Screening Programs in Resource-limited Settings

Abstract

Cervical cancer screening and management in the U.S. has adopted a risk-based approach. However, the majority of cervical cancer cases and deaths occur in resource-limited settings, where screening and management are not widely available. We describe a conceptual model that optimizes cervical cancer screening and management in resource-limited settings by utilizing a risk-based approach. The principles of risk-based screening and management in resource limited settings include (1) ensure that the screening method effectively separates low-risk from high-risk patients; (2) directing resources to populations at the highest cancer risk; (3) screen using HPV testing via self-sampling; (4) utilize HPV genotyping to improve risk stratification and better determine who will benefit from treatment, and (5) automated visual evaluation with artificial intelligence may further improve risk stratification. Risk-based screening and management in resource limited settings can optimize prevention by focusing triage and treatment resources on the highest risk patients while minimizing interventions in lower risk patients.

Citing Articles

Generalizable deep neural networks for image quality classification of cervical images.

Ahmed S, Befano B, Egemen D, Rodriguez A, Desai K, Jeronimo J Sci Rep. 2025; 15(1):6312.

PMID: 39984572 PMC: 11845747. DOI: 10.1038/s41598-025-90024-0.


Automated Image Clarity Detection for the Improvement of Colposcopy Imaging with Multiple Devices.

Ekem L, Skerrett E, Huchko M, Ramanujam N Biomed Signal Process Control. 2024; 100(Pt B).

PMID: 39669100 PMC: 11633643. DOI: 10.1016/j.bspc.2024.106948.


Temporal trends, spatial and spatiotemporal clusters of cervical cancer mortality in Brazil from 2000 to 2021.

Melo M, Lima S, Dos Santos A, Ribeiro C, Junior P, Silva T Sci Rep. 2024; 14(1):24436.

PMID: 39424895 PMC: 11489809. DOI: 10.1038/s41598-024-75378-1.


Expanding management strategies for cervical precancerous lesions in resource-limited settings: insights from a training center in a district hospital in Ghana.

Effah K, Tekpor E, Wormenor C, Bosoka S, Afetor M, Dugbazah A BMC Womens Health. 2024; 24(1):428.

PMID: 39060995 PMC: 11282615. DOI: 10.1186/s12905-024-03263-0.


Clinical Outcomes and Molecular Predictors of Pembrolizumab (Keytruda) as a PD-1 Immune Checkpoint Inhibitor in Advanced and Metastatic Cervical Cancer: A Systematic Review and Meta-Analysis.

Balan L, Cimpean A, Nandarge P, Sorop B, Balan C, Balica M Biomedicines. 2024; 12(5).

PMID: 38791070 PMC: 11117617. DOI: 10.3390/biomedicines12051109.